KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Molina Healthcare (MOH) EBITDA (2016 - 2025)

Molina Healthcare's EBITDA history spans 16 years, with the latest figure at -$162.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 81.49% year-over-year to -$162.0 million; the TTM value through Dec 2025 reached $781.0 million, up 72.79%, while the annual FY2025 figure was $788.0 million, 68.38% up from the prior year.
  • EBITDA for Q4 2025 was -$162.0 million at Molina Healthcare, down from $137.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $810.0 million in Q3 2021 and bottomed at -$875.0 million in Q4 2024.
  • The 5-year median for EBITDA is $335.0 million (2022), against an average of $238.6 million.
  • The largest annual shift saw EBITDA surged 8000.0% in 2021 before it tumbled 376.9% in 2024.
  • A 5-year view of EBITDA shows it stood at $191.0 million in 2021, then skyrocketed by 75.39% to $335.0 million in 2022, then decreased by 5.67% to $316.0 million in 2023, then crashed by 376.9% to -$875.0 million in 2024, then skyrocketed by 81.49% to -$162.0 million in 2025.
  • Per Business Quant, the three most recent readings for MOH's EBITDA are -$162.0 million (Q4 2025), $137.0 million (Q3 2025), and $373.0 million (Q2 2025).